Tesamorelin x 10 Vials
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) studied in endocrine, metabolic, and growth hormone research. This product is supplied as a 10-vial pack for controlled laboratory research.
The compound is particularly relevant to studies examining GHRH receptor signalling, pituitary somatotroph activity, growth hormone pathways, insulin-like growth factor biology, and metabolic regulation.
Research Use Only. Not for human consumption, self-administration, diagnosis, treatment, or prevention of disease.
Product Overview
Tesamorelin is a modified peptide based on the structure of human GHRH. Its primary research interest comes from its ability to interact with the GHRH receptor, providing researchers with a tool for investigating signalling pathways associated with endogenous growth hormone secretion.
Rather than being a growth hormone molecule itself, it is studied as a GHRH analogue. This distinction is important when evaluating its biological properties and research applications.
| Product Detail | Specification |
|---|---|
| Compound | Tesamorelin |
| Product type | Research peptide |
| Pack size | 10 vials |
| Peptide class | GHRH analogue |
| Primary pathway | GHRH receptor signalling |
| Research areas | Endocrine & metabolic biology |
| Intended use | Laboratory research only |
Tesamorelin and GHRH Research
GHRH is a naturally occurring hypothalamic peptide involved in regulating growth hormone release from the pituitary gland.
Researchers study GHRH analogues to better understand the relationship between hypothalamic signalling and pituitary growth hormone secretion.
Research involving this compound can examine:
- GHRH receptor activation
- Pituitary signalling
- Somatotroph biology
- Growth hormone regulation
- IGF-1 pathways
- Endocrine feedback mechanisms
- Metabolic signalling
These pathways are complex and involve interactions between the hypothalamus, pituitary gland, liver, peripheral tissues, and endocrine feedback systems.
Growth Hormone Signalling Research
The growth hormone axis is a major area of endocrinology research.
GHRH released from the hypothalamus can stimulate pituitary somatotroph cells, which then release growth hormone. Growth hormone subsequently influences several downstream pathways, including those involving insulin-like growth factor 1 (IGF-1).
Researchers can use GHRH analogues to investigate different stages of this signalling network.
Pituitary Research
Pituitary somatotroph cells respond to GHRH through specific receptors on the cell surface. Studying this interaction helps researchers examine intracellular signalling mechanisms involved in hormone secretion.
IGF-1 Research
Growth hormone signalling is connected with IGF-1 production, particularly in the liver. Researchers may investigate this relationship when studying endocrine feedback and metabolic biology.
Tesamorelin in Metabolic Research
The growth hormone axis interacts with multiple metabolic processes, including lipid metabolism, glucose regulation, protein metabolism, and energy balance.
This makes GHRH-related research relevant beyond traditional endocrine studies.
Laboratory research may examine relationships between hormonal signalling and:
- Adipose tissue biology
- Lipid metabolism
- Glucose metabolism
- Energy regulation
- Protein metabolism
- Endocrine feedback
Results from laboratory or clinical research should be interpreted within the specific study context and should not automatically be considered evidence for general therapeutic use.
Endocrine Feedback Mechanisms
The growth hormone axis operates through a sophisticated feedback system.
GHRH signalling, growth hormone secretion, IGF-1 activity, somatostatin, and hypothalamic feedback all contribute to maintaining endocrine balance.
Research into GHRH analogues can therefore help scientists study how these components interact.
This can be useful for investigating:
- Hormonal feedback loops
- Pituitary function
- Receptor signalling
- Growth hormone regulation
- IGF-1 biology
- Neuroendocrine communication
Tesamorelin vs Growth Hormone
An important distinction is that Tesamorelin is not recombinant human growth hormone.
It is a GHRH analogue that acts upstream within the growth hormone signalling pathway, whereas recombinant growth hormone directly supplies the hormone itself.
| Feature | Tesamorelin | Growth Hormone |
|---|---|---|
| Molecular class | GHRH analogue | Protein hormone |
| Primary research target | GHRH receptor | Growth hormone receptor |
| Research focus | Upstream endocrine signalling | Direct GH signalling |
| IGF-1 pathway | Indirectly related | Directly influenced |
| Research field | Endocrine biology | Endocrine & metabolic biology |
Tesamorelin x 10 Vials
This product is supplied as a 10-vial research pack.
The exact strength per vial should be confirmed using the product label and accompanying certificate of analysis.
| Pack Information | Details |
|---|---|
| Quantity | 10 vials |
| Compound | Tesamorelin |
| Format | Research peptide |
| Strength | Confirm from product label |
| Primary research area | GHRH and endocrine signalling |
| Intended application | Laboratory research |
Researchers should verify batch information, purity documentation, and storage requirements before beginning laboratory work.
Research Applications
GHRH Receptor Research
Investigate interactions between GHRH analogues and receptors involved in pituitary hormone regulation.
Pituitary Biology
Study signalling mechanisms associated with somatotroph cells and growth hormone secretion.
Endocrine Research
Examine communication between hypothalamic, pituitary, and peripheral endocrine pathways.
Metabolic Biology
Explore interactions between growth hormone signalling and metabolic pathways.
IGF-1 Research
Investigate relationships between growth hormone signalling and downstream IGF-1 biology.
Quality and Laboratory Considerations
Research laboratories should verify product specifications before use in an experimental setting.
Important documentation may include:
- Compound identity
- Vial strength
- Batch or lot number
- Purity information
- Certificate of analysis
- Packaging integrity
- Storage requirements
All research materials should be handled according to appropriate laboratory safety procedures and manufacturer documentation.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic GHRH analogue studied in research involving growth hormone signalling, pituitary biology, endocrine pathways, and metabolism.
What does Tesamorelin research focus on?
Research can focus on GHRH receptor signalling, somatotroph biology, growth hormone regulation, IGF-1 pathways, endocrine feedback, and metabolic biology.
How many vials are included?
This product contains 10 vials.
What strength are the vials?
The exact vial strength should be confirmed from the product label or certificate of analysis.
Is Tesamorelin the same as growth hormone?
No. It is a GHRH analogue rather than recombinant growth hormone. The two compounds interact with different points within the growth hormone signalling system.
Is this product intended for human use?
No. This product is supplied strictly for laboratory research and is not intended for human consumption or self-administration.
Research-Use Disclaimer
This product is intended exclusively for laboratory and scientific research. It is not a dietary supplement, approved general-purpose treatment, or product for self-administration.
Do not consume, inject, or administer this material to humans or animals. Researchers are responsible for complying with applicable laws, institutional requirements, laboratory safety procedures, and manufacturer documentation.
For research use only.





